Prolec-GE Waukesha, Inc., one of the nation's largest manufacturers of power transformers, is planning to build a second ...

The U.S. Federal Drug Administration (FDA) has granted Incyclix Bio Fast Track designation for INX-315 to treat ...

More than $13 million in incentives from North Carolina are pledged to a biotech company making a $700 million investment, a ...

Headlines across North Carolina Monday and Tuesday included 400 new jobs in Holly Springs; flooding risk in the mountains eases; Congressman Chuck Edwards accused for hitting someone with a clipboard ...

Governor Josh Stein announced Monday that Genentech, one of the world’s premiere biotechnology companies, will invest $700 ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

The U.S. secured over $1 billion in new manufacturing investment today on the back of President Trump’s push for more domestic production. Receive undervalued stocks, resilient to market uncertainty, ...

Genentech, a Bay Area-based biotech firm and member of the Switzerland-based Roche Group, plans to develop a $700 million pharmaceutical manufacturing facility in Holly Springs, approximately 20 miles ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

North Carolina's life sciences sector continues to attract major investments with the potential for thousands of jobs.

Genentech, one of the world's premiere biotechnology companies headquartered in South San Francisco, California, announced it ...